Medison Pharma

Medison Pharma

Pharmaceutical Manufacturing

Always Ahead

About us

Medison is a global pharma company focused on providing access to highly innovative therapies to patients in international markets. Medison is the first to create an international commercialization platform for highly innovative therapies, helping to save and improve lives by making the best available novel treatments accessible to patients in international markets. Medison has a track record of multi-territorial partnerships with leading pharmaceutical and biotech companies seeking to expand their global reach.

Industry
Pharmaceutical Manufacturing
Company size
501-1,000 employees
Headquarters
Petach Tikva
Type
Privately Held
Founded
1996
Specialties
healthcare solutions, healthcare industry, biotechnology, orphan diseases, rare diseases, and healthcare innovation

Locations

Employees at Medison Pharma

Updates

  • View organization page for Medison Pharma, graphic

    25,922 followers

    We are happy to announce that Liat Lavi is joining Medison as our VP Corporate Affairs. At Medison, Liat will be a member of our Global Leadership Team and will oversee our Corporate Affairs strategy, focusing on Communication, Public Affairs, and Corporate Social Responsibility, ensuring we continue to make a significant impact on global healthcare by accelerating access to highly innovative therapies for patients suffering from rare and severe diseases worldwide. Liat brings 20 years of extensive experience in the pharmaceutical industry, spanning Communication, Public Affairs, Market Access, and Commercial Operations on local and global levels. She has successfully led strategic initiatives and managed large-scale projects in global markets, particularly in Oncology and Emerging Markets. We are confident that Liat's expertise and leadership will be instrumental in advancing Medison's mission. Welcome Liat! #WelcometotheTeam #AlwaysAhead #GrowasOne #MedisonMission

    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    We at Medison, together with our long-standing global partner Alnylam Pharmaceuticals Inc., are pleased that we have achieved an important milestone for Australian patients with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). As the creator and leader of the global partnership category, we are thrilled to see our vision of accelerating access to highly innovative therapies in international markets becoming a reality and we will continue to work for the benefit of those affected by rare and severe diseases. More information can be found on our website: https://lnkd.in/de6Qk7Sz

    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    We believe that diversity drives our vision and mission forward. It takes people from different parts of the world united by a common purpose. Each country brings its unique challenges and needs, different viewpoints, and a variety of approaches that it perceives to be the best way to achieve our mission. During the Americas Summit held in Toronto, Canada, Medisonians from Canada and Latin American countries including Brazil, Argentina, Colombia and others, met together, celebrating the diversity and emphasizing that we are united in our ability to share best practices, learn from one and other, and enjoy what each person, in each country, has to offer. We also took the opportunity to share our tables with each other as the team brought local treats and delicacies such as maple syrup, Brigadeiros and Alfajores. The summit gave us an opportunity to participate in workshops and seminars and celebrate with our colleagues the many successes and exciting achievements Medison has experienced in the region. Our shared DNA was evident throughout and will continue to be what guides and leads our growth and expansion in the Americas region. The summit was a huge success, and we’d like to thank all who worked tirelessly to ensure that all goals were met and that everyone felt at home. #MedisonMission #AlwaysAhead #GrowAsOne #WeCare 

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    We are continuing to hold our regional summits, and recently our APAC team gathered in Sydney, Australia.   Members from Australia, South Korea, Taiwan, Singapore, and Hong Kong met with our Global Leadership team, engaging in lectures, workshops, and discussions aimed at enhancing our regional collaboration and highlighting our continued strategic growth and expansion into the Asia-Pacific region.    Our commitment to bridging the access gap and providing lifesaving therapies to patients in the region was evident as we celebrated many significant milestones achieved through the hard work and determination of our team. As Medison continues to #GrowAsOne, we are committed to being #AlwaysAhead, embracing innovation and pushing the boundaries for the benefit of the patients in the APAC region.   Thank you to everyone who made this event unforgettable. We look forward to our continued journey together. #MedisonMission #OneMedison 

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    We are happy to welcome Jinyong Noh as the Pricing and Market Access Senior Manager for South Korea, Medison APAC.   As a pharmacist and a Ph.D. candidate specializing in pharmacoeconomics, Jinyong has extensive experience in key roles at leading pharmaceutical companies. He has developed strategic approaches and successfully led efforts to secure reimbursement for innovative therapies.   Jinyong is committed to addressing access and affordability issues, which align perfectly with Medison's mission to accelerate patient access to lifesaving therapies in international markets, particularly in the APAC region.   We are looking forward to the expertise Jinyong will bring to our journey and wish him the best of luck!   Welcome to Medison, Jinyong! #MedisonMission #AlwaysAhead #GrowAsOne

    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    We are happy to welcome Robert Pająk to Medison EPM as Business Unit Head Oncology, Poland.   Robert brings more than 20 years of experience in oncology sales & marketing, having held key positions in leading pharmaceutical companies.   Robert's extensive background in the oncology market and his proven leadership skills make him a valuable addition to our team in Poland.   Welcome to Medison, Robert! #MedisonMission #AlwaysAhead #GrowAsOne

    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    We are excited to welcome Yoon joo Huh as the Regulatory Affairs and Pharmacovigilance Manager for South Korea, Medison APAC.   With over a decade of experience, Yoonjoo brings deep expertise and understanding in regulatory affairs, pharmacovigilance, and quality assurance within the biopharmaceutical industry.  Trained as a pharmacist and specializing in pharmaceutical science and immunology, Yoonjoo has held key positions in renowned pharmaceutical companies. She has successfully managed complex projects and ensured adherence to stringent quality standards across regulatory affairs, pharmacovigilance, and quality assurance.   We are confident that Yoonjoo’s skills and dedication will greatly contribute to our continued growth in the APAC region and fulfill our mission. #MedisonMission #AlwaysAhead #GrowAsOne

    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    Last week, we held our European Partner Markets Regional Summit in Bratislava, Slovakia.   As the Creator and Leader of the Global Partnership Category, we have a responsibility to our patients in international markets. We can fulfill this responsibility by living our core value of #GrowAsOne. To do so, we place great emphasis on unity, fostering connection and collaboration.   The EPM summit showcased this as Medisonians from more than 20 countries joined together for professional workshops, panels, and discussions (and a lot of fun and great vibes!), reflecting our commitment to staying #AlwaysAhead, and promoting creativity, knowledge sharing and cross-functional collaboration.   We extend our sincere gratitude to everyone for their active involvement, dedication and hard work, both during the summit and throughout their daily work at Medison.   It was a pleasure seeing each other, celebrating and recognizing the remarkable achievements of our EPM team. We look forward to continued growth, collaboration, and success as #OneMedison and are looking forward to meeting everyone again soon. #MedisonMission

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    We are happy to welcome Hui-Yun, Claudia Tsai to Medison APAC as Regulatory Affairs and PV Manager, Taiwan. Claudia comes to us with an extensive background in regulatory affairs, spanning pharmaceuticals, medical devices, and other sectors. Claudia’s expertise in navigating complex regulatory landscapes and her adeptness at strategic planning will be instrumental as Medison continues to grow and expand in APAC. Welcome aboard, Claudia! #MedisonMission #AlwaysAhead #GrowAsOne  

    • No alternative text description for this image
  • View organization page for Medison Pharma, graphic

    25,922 followers

    We are happy to welcome Kate (Eun-Sil) OH to Medison APAC as our Medical Director in South Korea.   Kate, is a physician by education and training and brings a wealth of experience in the field of medical affairs, particularly in oncology, endocrinology, and immunology. She has held roles in various leading pharma companies and medical organizations, where she led teams, managed significant clinical studies, and achieved notable milestones in regulatory approvals and strategic program management.   With Kate joining Medison, our growing presence in South Korea and across the APAC region continues, and her knowledge and leadership will be a great asset in our journey.   Welcome aboard, Kate! #WelcometotheTeam #MedisonMission #AlwaysAhead

    • No alternative text description for this image

Similar pages